Numbers first: 2 mg/mL · orforglipron.
I want to know what the trade-off actually is rather than which option is fashionable.
I would rather have a defensible reason than a marginal improvement.
Which axes does this decision turn on?
At 2 mg/mL a 0.25 mg draw is 12.5 units on a U-100 barrel and a 2.4 mg draw is 120. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. 120 units will not fit a 1 mL U-100 barrel in one draw, which makes the large end the constraint rather than the small one. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.
Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.
Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.
Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.
U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.
The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.
Check the vial can physically hold the volume before you draw it up.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThe honest answer is that a wide range of volumes works and that the extremes at either end cause avoidable problems.
For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.
Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.
A concentration calculated to three decimal places from a diluent volume measured to one is false precision.
Write the concentration on the label at reconstitution, in units per dose.
edited 2 Dec 2025 by bounty_hunter_q — tightened the wording; no substantive change
The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.
Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.
Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.
Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.
Measure a volume you can actually measure. Round numbers, real syringes.
The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.
Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.
Nothing here is medical advice, and research-use material is not approved for human use.
Concentration equals content over volume, and content is not label claim.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.